Preliminary evidence that rivastigmine-induced inhibition of serum butyrylcholinesterase activity improves behavioral symptoms in Japanese patients with Alzheimer's disease.

about

Preliminary evidence that rivastigmine-induced inhibition of serum butyrylcholinesterase activity improves behavioral symptoms in Japanese patients with Alzheimer's disease.

Item

http://www.wikidata.org/entity/Q47956147

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Preliminary evidence that riva ...... ents with Alzheimer's disease.

@en

Preliminary evidence that riva ...... ents with Alzheimer's disease.

@nl

type

Item

label

Preliminary evidence that riva ...... ents with Alzheimer's disease.

@en

Preliminary evidence that riva ...... ents with Alzheimer's disease.

@nl

prefLabel

Preliminary evidence that riva ...... ents with Alzheimer's disease.

@en

Preliminary evidence that riva ...... ents with Alzheimer's disease.

@nl

P1476

Preliminary evidence that riva ...... ents with Alzheimer's disease.

@en

P2093

Nobuyasu Bando

http://www.w3.org/2001/XMLSchema#string

Yu Nakamura

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.

Cognitive and affective changes in mild to moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors: a 6-month observational study.

A 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer's Disease

Butyrylcholinesterase as a prognostic marker: a review of the literature

Butyrylcholinesterase: K variant, plasma activity, molecular forms and rivastigmine treatment in Alzheimer's disease in a Southern Brazilian population.

Rivastigmine patch ameliorates depression in mild AD: preliminary evidence from a 6-month open-label observational study.

Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.

Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.

P304

1306-1312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/GGI.12865

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27546156

http://www.w3.org/2001/XMLSchema#string